At Lennham, we strive to improve the metabolic and pharmacological profile of drugs through deuterium chemistry.

We are a team of industry experts who believe that deuterium chemistry is an underutilized technology that may yield products with superior properties.

Our thoughtful approach has yielded significantly improved products with strong patent protection. We do this by:

• Identifying chemical compounds that could benefit from a modification to their metabolic or pharmacokinetic properties.

• Generating experimental data to determine if deuterium chemistry can influence one or more metabolic or pharmacokinetic properties and support broad patent protection.

• Advancing products with high probability of clinical success and significant commercial potential.